Bibliographic Info
GuidelineWHO guidelines for malaria, 3 June 2022.
Year of Publication2022
Issuing InstitutionWHO
Recommendation
Status
Maintained
Recommended against
Conditional
Certainty of evidence
Very low
Mass relapse prevention (MRP) to reduce transmission of P. vivax: Mass treatment with an 8-aminoquinoline medicine alone to reduce the transmission of P. vivax is not recommended.
Also Featured In
This recommendation also appears in the following guidelines:
Guideline
WHO guidelines for malaria, 25 November 2022.
Year2022
InstitutionWorld Health Organization
Guideline
WHO guidelines for malaria, 16 October 2023.
Year2023
InstitutionWorld Health Organization
Guideline
WHO Guidelines for malaria, 14 March 2023
Year2023
InstitutionWHO
Guideline
WHO guidelines for malaria, 30 November 2024.
Year2024
InstitutionWHO